Prasad Anand M, Ketsawatsomkron Pimonrat, Nuno Daniel W, Koval Olha M, Dibbern Megan E, Venema Ashlee N, Sigmund Curt D, Lamping Kathryn G, Grumbach Isabella M
Department of Medicine, Carver College, University of Iowa, Iowa City, United States.
Department of Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, United States.
Vascul Pharmacol. 2016 Dec;87:172-179. doi: 10.1016/j.vph.2016.09.007. Epub 2016 Sep 20.
Angiotensin-II (Ang-II) is a well-established mediator of vascular remodeling. The multifunctional calcium-calmodulin-dependent kinase II (CaMKII) is activated by Ang-II and regulates Erk1/2 and Akt-dependent signaling in cultured smooth muscle cells in vitro. Its role in Ang-II-dependent vascular remodeling in vivo is far less defined. Using a model of transgenic CaMKII inhibition selectively in smooth muscle cells, we found that CaMKII inhibition exaggerated remodeling after chronic Ang-II treatment and agonist-dependent vasoconstriction in second-order mesenteric arteries. These findings were associated with increased mRNA and protein expression of smooth muscle structural proteins. As a potential mechanism, CaMKII reduced serum response factor-dependent transcriptional activity. In summary, our findings identify CaMKII as an important regulator of smooth muscle function in Ang-II hypertension in vivo.
血管紧张素 II(Ang-II)是一种公认的血管重塑介质。多功能钙调蛋白依赖性激酶 II(CaMKII)可被 Ang-II 激活,并在体外培养的平滑肌细胞中调节 Erk1/2 和 Akt 依赖性信号传导。其在体内 Ang-II 依赖性血管重塑中的作用尚不清楚。利用平滑肌细胞中选择性抑制 CaMKII 的转基因模型,我们发现,抑制 CaMKII 会加剧慢性 Ang-II 处理后的重塑以及二级肠系膜动脉中激动剂依赖性血管收缩。这些发现与平滑肌结构蛋白的 mRNA 和蛋白质表达增加有关。作为一种潜在机制,CaMKII 降低了血清反应因子依赖性转录活性。总之,我们的研究结果表明 CaMKII 是体内 Ang-II 高血压中平滑肌功能的重要调节因子。